Health Canada approves Moderna's mRNA RSV vaccine, company says

  • 📰 CP24
  • ⏱ Reading Time:
  • 21 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 67%

Health اخبار

National,Social

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.

Moderna says Health Canada has approved its mRNA vaccine, shown in a handout photo, to protect against respiratory syncytial virus in adults age 60 and older. THE CANADIAN PRESS/HO-Moderna **MANDATORY CREDIT**

In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older. According to the Public Health Agency of Canada's wastewater surveillance, the level of RSV circulating is currently"moderate" across much of the country.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 30. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
منبع: SooToday - 🏆 8. / 85 ادامه مطلب »

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
منبع: BurnabyNOW_News - 🏆 14. / 77 ادامه مطلب »

Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
منبع: PGCitizen - 🏆 65. / 51 ادامه مطلب »

Health Canada approves Moderna’s mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
منبع: CHEK_News - 🏆 59. / 55 ادامه مطلب »

Health Canada approves Moderna's mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year.
منبع: CTVNews - 🏆 1. / 99 ادامه مطلب »

Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
منبع: globeandmail - 🏆 5. / 92 ادامه مطلب »